Trials / Unknown
UnknownNCT03295903
Cannabinoid Supplementation on Vascular and Cognitive Function
The Effects of Cannabinoids on Vascular and Cognitive Function in Young and Old Healthy Adults.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Cannabidiol (CBD) is a bioactive cannabinoid compound in marijuana (cannabis sativa), but unlike Δ9 tetrahydrocannabinol (THC), lacks the psychoactivity effect of THC. Available evidence suggests that there are marked therapeutic CBD effects for diverse disease processes including inflammation, cancers, psychosis, and epileptic seizures. The purpose of this study, in both younger and older healthy humans, is to improve our understanding of how CBD might control and regulate blood vessel health as well as cognitive and exercise performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cannabidiol supplement | Subjects will be administered in a double-blinded, randomized and cross-over design |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2021-09-30
- Completion
- 2021-10-01
- First posted
- 2017-09-28
- Last updated
- 2019-10-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03295903. Inclusion in this directory is not an endorsement.